These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32514112)

  • 1. Multilayered VBC score predicts sgRNAs that efficiently generate loss-of-function alleles.
    Michlits G; Jude J; Hinterndorfer M; de Almeida M; Vainorius G; Hubmann M; Neumann T; Schleiffer A; Burkard TR; Fellner M; Gijsbertsen M; Traunbauer A; Zuber J; Elling U
    Nat Methods; 2020 Jul; 17(7):708-716. PubMed ID: 32514112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroporation-Based CRISPR/Cas9 Gene Editing Using Cas9 Protein and Chemically Modified sgRNAs.
    Laustsen A; Bak RO
    Methods Mol Biol; 2019; 1961():127-134. PubMed ID: 30912044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
    Graf R; Li X; Chu VT; Rajewsky K
    Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9-mediated genome editing efficiently creates specific mutations at multiple loci using one sgRNA in Brassica napus.
    Yang H; Wu JJ; Tang T; Liu KD; Dai C
    Sci Rep; 2017 Aug; 7(1):7489. PubMed ID: 28790350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs.
    Kundert K; Lucas JE; Watters KE; Fellmann C; Ng AH; Heineike BM; Fitzsimmons CM; Oakes BL; Qu J; Prasad N; Rosenberg OS; Savage DF; El-Samad H; Doudna JA; Kortemme T
    Nat Commun; 2019 May; 10(1):2127. PubMed ID: 31073154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative optimization of combinatorial CRISPR screens.
    Li R; Klingbeil O; Monducci D; Young MJ; Rodriguez DJ; Bayyat Z; Dempster JM; Kesar D; Yang X; Zamanighomi M; Vakoc CR; Ito T; Sellers WR
    Nat Commun; 2022 May; 13(1):2469. PubMed ID: 35513429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choosing CRISPR-based screens in cancer.
    Marx V
    Nat Methods; 2017 Mar; 14(4):343-346. PubMed ID: 28362439
    [No Abstract]   [Full Text] [Related]  

  • 8. A Novel White-to-Blue Colony Formation Assay to Select for Optimized sgRNAs.
    Wei C; Chen T; Zhang Y; Wang Y; Shi D; Jiang Z; Li K; Xiao L; Shen J
    Mol Biotechnol; 2021 Jan; 63(1):1-12. PubMed ID: 33047235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient CRISPR/Cas9-mediated biallelic gene disruption and site-specific knockin after rapid selection of highly active sgRNAs in pigs.
    Wang X; Zhou J; Cao C; Huang J; Hai T; Wang Y; Zheng Q; Zhang H; Qin G; Miao X; Wang H; Cao S; Zhou Q; Zhao J
    Sci Rep; 2015 Aug; 5():13348. PubMed ID: 26293209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SliceIt: A genome-wide resource and visualization tool to design CRISPR/Cas9 screens for editing protein-RNA interaction sites in the human genome.
    Vemuri S; Srivastava R; Mir Q; Hashemikhabir S; Dong XC; Janga SC
    Methods; 2020 Jun; 178():104-113. PubMed ID: 31494246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and rational design of guide RNAs for efficient CRISPR/Cas9-mediated mutagenesis in Ciona.
    Gandhi S; Haeussler M; Razy-Krajka F; Christiaen L; Stolfi A
    Dev Biol; 2017 May; 425(1):8-20. PubMed ID: 28341547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guide RNA modification as a way to improve CRISPR/Cas9-based genome-editing systems.
    Filippova J; Matveeva A; Zhuravlev E; Stepanov G
    Biochimie; 2019 Dec; 167():49-60. PubMed ID: 31493470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A G-quadruplex motif at the 3' end of sgRNAs improves CRISPR-Cas9 based genome editing efficiency.
    Nahar S; Sehgal P; Azhar M; Rai M; Singh A; Sivasubbu S; Chakraborty D; Maiti S
    Chem Commun (Camb); 2018 Mar; 54(19):2377-2380. PubMed ID: 29450416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPcut: A novel tool for designing optimal sgRNAs for CRISPR/Cas9 based experiments in human cells.
    Dhanjal JK; Radhakrishnan N; Sundar D
    Genomics; 2019 Jul; 111(4):560-566. PubMed ID: 29605634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions.
    Munoz DM; Cassiani PJ; Li L; Billy E; Korn JM; Jones MD; Golji J; Ruddy DA; Yu K; McAllister G; DeWeck A; Abramowski D; Wan J; Shirley MD; Neshat SY; Rakiec D; de Beaumont R; Weber O; Kauffmann A; McDonald ER; Keen N; Hofmann F; Sellers WR; Schmelzle T; Stegmeier F; Schlabach MR
    Cancer Discov; 2016 Aug; 6(8):900-13. PubMed ID: 27260157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of
    Pelletier S; Tummers B; Green DR
    STAR Protoc; 2020 Dec; 1(3):100181. PubMed ID: 33377075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening.
    Kiessling MK; Schuierer S; Stertz S; Beibel M; Bergling S; Knehr J; Carbone W; de Vallière C; Tchinda J; Bouwmeester T; Seuwen K; Rogler G; Roma G
    BMC Genomics; 2016 Sep; 17(1):723. PubMed ID: 27613601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Split-and-Click" sgRNA.
    Taemaitree L; Shivalingam A; El-Sagheer AH; Brown T
    Methods Mol Biol; 2021; 2162():61-78. PubMed ID: 32926378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.
    Paquet D; Kwart D; Chen A; Sproul A; Jacob S; Teo S; Olsen KM; Gregg A; Noggle S; Tessier-Lavigne M
    Nature; 2016 May; 533(7601):125-9. PubMed ID: 27120160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generating Mutant Renal Cell Lines Using CRISPR Technologies.
    Perretta-Tejedor N; Freke G; Seda M; Long DA; Jenkins D
    Methods Mol Biol; 2020; 2067():323-340. PubMed ID: 31701460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.